IGF-1, a major mediator of the growth-promoting effects of growth hormone, and IGFBP-3, a central binding protein for IGF-1 that carries IGF-1 in the bloodstream, have been used to assess growth hormone excess or deficiency [5]. Here, GH1 is linked to hyperinsulinemic hypoglycemia, familial, 4.